Literature DB >> 12418067

Age-related changes in ovarian volume, antral follicle counts and basal FSH in women with normal reproductive health.

Ahmet Erdem1, Mehmet Erdem, Kutay Biberoglu, Ozkan Hayit, Murat Arslan, Rifat Gursoy.   

Abstract

OBJECTIVE: To investigate the relation between ultrasound-based ovarian volume and antral follicle counts and hormonal parameters of ovarian reserve in a group of women with normal reproductive health. STUDY
DESIGN: Prospective study. One hundred eight women with at least one previous pregnancy reaching term were divided into three age groups (group 1 = 35-39 years, group 2 = 40-44 years, and group 3 = 45-50 years). Basal hormone measurements and transvaginal ultrasonography estimation of ovarian volume and follicle counts were performed in the early follicular phase (day 3) of the menstrual cycle.
RESULTS: There were significant differences in FSH (P < .0001) and E2 (P < .002) levels when group I was compared to groups II and III. There was a significant decrease in mean follicle counts (MFC) between groups I and III (P < .05). The decrease in mean ovarian volume (MOV) with age was not statistically significant. Age strongly correlated with MFC (r = -.38, P < .001) and weakly with MOV (r = -.29, P < .05). However, basal FSH correlated positively with age (r = .50, P < .001) and negatively with MOV (r = -.590, P < .001) and MFC (r = -.658, P < .001). Basal E2 correlated with MOV (r = .50, P < .001) and MFC (r = .50, P < .001). There was also a strong positive correlation between MFC and MOV (r = .777, P < .001).
CONCLUSION: There was a decrease in MOV and MFC with aging coincident with increasing basal FSH levels after age 35 in women with normal reproductive health.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12418067

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  11 in total

1.  Polycystic ovary morphology: age-based ultrasound criteria.

Authors:  Hyun-Jun Kim; Judith M Adams; Jens A Gudmundsson; Gudmundur Arason; Cindy T Pau; Corrine K Welt
Journal:  Fertil Steril       Date:  2017-08-12       Impact factor: 7.329

2.  The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance.

Authors:  Erica B Johnstone; Mitchell P Rosen; Rebecca Neril; Deborah Trevithick; Barbara Sternfeld; Rosemary Murphy; Carolyne Addauan-Andersen; Daniel McConnell; Renee Reijo Pera; Marcelle I Cedars
Journal:  J Clin Endocrinol Metab       Date:  2010-08-18       Impact factor: 5.958

3.  Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age.

Authors:  S Alsamarai; J M Adams; M K Murphy; M D Post; D L Hayden; J E Hall; C K Welt
Journal:  J Clin Endocrinol Metab       Date:  2009-10-21       Impact factor: 5.958

4.  Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause.

Authors:  Corrine K Welt; Enrico Carmina
Journal:  J Clin Endocrinol Metab       Date:  2013-09-24       Impact factor: 5.958

5.  Evaluation of ovarian reserve in infertile patients.

Authors:  Mehmet Fırat Mutlu; Ahmet Erdem
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-09-01

6.  Follicle number, not assessments of the ovarian stroma, represents the best ultrasonographic marker of polycystic ovary syndrome.

Authors:  Jacob P Christ; Amy D Willis; Eric D Brooks; Heidi Vanden Brink; Brittany Y Jarrett; Roger A Pierson; Donna R Chizen; Marla E Lujan
Journal:  Fertil Steril       Date:  2013-11-01       Impact factor: 7.329

7.  The relationship between Anti-Müllerian hormone and other reproductive parameters in normal women and in women with polycystic ovary syndrome.

Authors:  N Koutlaki; M Dimitraki; S Zervoudis; C Poiana; A Psillaki; I Nikas; A Liberis; C Badiu; V Liberis
Journal:  J Med Life       Date:  2013-06-25

8.  ART outcome in young women with premature ovarian aging.

Authors:  Meenakshi Dua; Vandana Bhatia; Sonia Malik; Ved Prakash
Journal:  J Midlife Health       Date:  2013-10

9.  Follicle Stimulating Hormone and Anti-Müllerian Hormone among Fertile and Infertile Women in Ile-Ife, Nigeria: Is there A Difference?

Authors:  Temitope Okunola; Kayode Olusegun Ajenifuja; Olabisi Morebise Loto; Afolabi Salawu; Stephen Oluseyi Omitinde
Journal:  Int J Fertil Steril       Date:  2016-11-11

10.  Does the Ovarian Stimulation Phase Length Predict In vitro Fertilization Outcomes?

Authors:  Brie Alport; Allison Case; Hyun Lim; Angela Baerwald
Journal:  Int J Fertil Steril       Date:  2011-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.